Pharmafile Logo
Pharmafocus logo
Advanced Search

Torisel

Showing 3 posts of 3 posts found.

Torisel-Avastin combo fails in kidney cancer

August 13, 2012
Research and Development, Sales and Marketing R&D, Sutent, Torisel, avastin, failure, rcc

Combining Pfizer’s Torisel and Roche’s Avastin does not increase survival rates for advanced kidney cancer patients. This is according to …

News

Torisel fails in head-to-head study with Nexavar

May 16, 2012
Research and Development, Sales and Marketing Bayer, Nexavar, Pfizer, Torisel, inlyta, rcc

Pfizer’s kidney cancer drug Torisel has failed to best Bayer’s Nexavar in a head-to-head trial.  The Phase III study was …

News

NICE refuses cancer drugs Arzerra, Torisel and Levact

October 27, 2010
Sales and Marketing Arzerra, GSK, NICE, Napp Pharmaceuticals, Pfizer, Torisel, Treanda, cancer drugs

NICE has refused to recommend a trio of cancer drugs for NHS use – but in two cases says this …

News
The Gateway to Local Adoption Series

Latest content

Major funding opportunity opens for early cancer diagnostics

September 4, 2026

Androlabs receives UK authorisation for new Testavan presentation

September 4, 2026

CEPI backs African-led Bundibugyo Ebola vaccine development

September 3, 2026

Cytomos appoints life sciences executive to board

September 2, 2026

Cell therapy partnership aims to bring liver disease treatment closer to US patients

September 1, 2026